News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
scanx.trade Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides an analysis of Abivax Sa (NASDAQ: ABVX), highlighting a weak near-term sentiment but potential long-term strength. It details specific AI-generated trading strategies including long, breakout, and short positions, along with support and resistance levels across different time horizons. The analysis suggests …
Bank of America Corp DE reduced its stake in LivaNova PLC (NASDAQ:LIVN) by 30.6% in the first quarter, selling 235,233 shares but still retaining 533,017 shares valued at $33.9 million. Institutional investors now own 97.64% of the company's stock. LivaNova recently surpassed earnings expectations, …
Handelsbanken Fonder AB significantly increased its stake in Roivant Sciences Ltd. during the second quarter, now holding 177,209 shares valued at $6.27 million. Institutional investors collectively own 64.76% of Roivant's stock, despite recent insider selling totaling approximately 2.06 million shares. Analysts maintain a "Moderate …
Wall Street Zen has upgraded Vivani Medical (NASDAQ:VANI) from a "sell" to a "hold" rating, contributing to a consensus "Hold" rating with an average price target of $3.75. Analyst opinions are varied, with Lake Street Capital initiating coverage with a "buy" rating and a …
Jericho Capital Asset Management L.P. and its managing member, Josh Resnick, have reported a 6.6% beneficial ownership stake in Workiva Inc. (WK) Class A common stock. This disclosure was made in a Schedule 13G filing, indicating shared voting and dispositive power over 3,482,515 shares. …
Vivani Medical (NASDAQ: VANI) announced full enrollment in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also signed a non-exclusive agreement with Novo Nordisk for evaluating NPM-139 and its NanoPortal technology. Additionally, Vivani …
This article states that Vivakor has filed an NT 10-Q notice, indicating an inability to timely file all or part of a form 10-Q or 10-QSB. This notice is filed under Rule 12b25. The content explicitly states "Document," implying the document itself is the …
PAR Investment Partners, L.P., along with PAR Group II, L.P. and PAR Capital Management, Inc., has disclosed a beneficial ownership of 4,292,733 American Depository Shares (ADSs) in trivago N.V. (TRVG). This stake represents 18.6% of trivago's Class A Shares, with the PAR entities holding …
This article provides a detailed overview of Clarivate PLC (CLVT) stock, including its current price, market capitalization, key financial figures, and recent performance. It also covers analyst ratings, a technical analysis summary, company profile, and major shareholders. The stock's current rating is "Hold" with …
TCG Crossover investment entities and Chen Yu have reported a significant stake in Abivax (ABVX) through American Depositary Shares (ADSs). TCG Crossover Fund I, L.P. and its general partner hold 5.7% of Abivax's ordinary shares, while TCG Crossover Fund II, L.P. holds 1.3%. Chen …
The boss of insurer Aviva has urged the new Chancellor not to "fly kites" with prospective policies ahead of the October budget after last year's speculation around pension changes. Chief executive Dame Amanda Blanc said widespread rumours that the Government might cut or restrict …
Bank of America Corp DE increased its stake in Innoviva, Inc. (NASDAQ:INVA) by 6.6% in the first quarter, now owning 1,619,994 shares valued at approximately $37.75 million. Institutional investors and hedge funds collectively own 99.12% of Innoviva, and the stock currently has an average …
This article lists various Exchange Traded Funds (ETFs) that hold Clarivate PLC (16A) stocks, providing investors with options to invest in the company indirectly. Each ETF entry includes details such as market value, weight of Clarivate PLC in the fund, issuer, management style, focus, …
Insurer Aviva has seen half-year earnings surge by nearly a quarter as it cheered action to "quickly" improve profitability at Direct Line since buying the firm in a £3.7 billion deal. The group reported a better-than-expected 24% surge in operating profits to £1.33 billion …
trivago (NASDAQ:TRVG) recently reported strong earnings, leading to a share price increase. However, the analysis highlights that while the company's free cash flow significantly exceeded its statutory profit, resulting in a negative accrual ratio, there was an unusual tax benefit of €4.9m that boosted …
This document is an 8-K current report filed by Vivakor. The 8-K form is used by public companies to announce significant events that investors should know about. Without further content, the specific nature of this significant event is unknown.
This article reports on Vivakor Inc.'s Form 8K filing for August 13. The company, trading under the symbol VIVK, experienced a slight dip in its stock performance. The content primarily serves as a notice of the filing and a brief update on the stock's …
In the latest trading session, Carnival (CCL) closed at $28.42, marking a +2.71% move from the previous day. This change outpaced the S&P 500's 0.65% gain on the day. At the same time, the Dow added 0.13%, and the tech-heavy Nasdaq gained 0.81%. Prior …
Sharemaestro market context Trend signal started 52 weeks +8.0%Vivani Medical (NASDAQ:VANI) reported a quarterly loss of $0.07 per share, exceeding analyst estimates by $0.01. Despite beating expectations, shares fell 2.2% to $1.34. The company has an average "Hold" rating from analysts with a target price of $3.75, and director Gregg Williams recently …
Vivani Medical (VANI) has reported a net loss of $6.4 million for Q2 2026 and $13.2 million for the first half of 2026, with cash and equivalents totaling $19.9 million, which is projected to fund operations into Q2 2027. The company is advancing its …
This article reports on the filing of a Form 8K by Vivani Medical Inc. on August 13th, as tracked by Investing.com. The brief mention indicates a financial disclosure event for the company, with the stock symbol VANI noted to have experienced a -2.19% change.
Vivani Medical reported its second-quarter 2026 financial results, highlighting significant progress in its clinical development, including the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also announced a non-exclusive agreement …
Vivani Medical (VANI) reported its Q2 2026 financial results, highlighting the successful dosing of all 20 participants in its Phase 1 SLIM-1™ trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also announced a non-exclusive agreement with Novo …
Search by ticker symbol or company name and select a result to open its chart.